To identify additional biomarkers that predict sensitivity to GSK690, we explored both mutational and gene expression features of SCLC cell lines from available CCLE data [24] LSD1 expression level alone did not correlate with drug sensitivity (Fig. 2B,C). Here, KDM1A is linked to small cell lung carcinoma.